Net worth
$37.2B
Forbes Real-Time · as of Sep 24, 2026
Latest moves
No moves from Peter Thiel in the digest yet. The archive grows every morning.
Recent SEC filings
No SEC filings in the last 90 days.
Form 4 insider trades post within 2 business days. 13F fund holdings can arrive 45 days after quarter end. New to filings? Read Filings 101.
Footprint
Companies
Palantir Technologies Inc.PLTR · NASDAQ · Co-founder, director · 4.5% · as of Sep 2024 · $192.59 ▲ 0.42%
source ↗More
- Ticker
- PLTR
- Exchange
- NASDAQ
- Role
- Co-founder, director; one of three founders controlling the Founder Voting Trust (all 1,005,000 Class F shares; ~27.7% of voting power for director elections)
- Stake
- 4.5% of Class A beneficially (100,335,000 sh) — below 5% threshold
- Stake as of
- 2024-09-30
Palantir — March 2, 2026 sale of 1,999,980 shares at ~$141-$147 under 10b5-1 plan adopted 2025-11-14; indirect holdings after: Rivendell 7 LLC 34,260,451 sh, PLTR Holdings LLC 20,823,993 sh, Rivendell 25 LLC 53,487 shPLTR · NASDAQ · director · as of Mar 2026 · $192.59 ▲ 0.42%
source ↗More
- Ticker
- PLTR
- Exchange
- NASDAQ
- Role
- director (Form 4)
- Stake as of
- 2026-03-02
Founders Fund (venture capital; numerous fund entities on EDGAR e.g. Founders Fund IX, LP CIK 0001971631, Founders Fund Growth IV, LP CIK 0002112131)Co-founder and general partner
source ↗Mithril Capital (Mithril LP / Mithril II LP and GPs) — joint 10% owner filer with Thiel on Fractyl Health (GUTS) Form 3affiliated investment firm · as of Feb 2024
source ↗More
- Role
- affiliated investment firm (Thiel listed as reporting owner)
- Stake as of
- 2024-02-01
Stakes
SpaceX (private; Forbes notes planned 2026 IPO at ~$1.75T valuation)undisclosed · as of 2026
source ↗Meta Platforms — sold most of stake; left board 2022META · small/unspecified · as of 2022 · $777.59 ▲ 4.50%
source ↗Chemomab Therapeutics Ltd. (ADS) — 22,631,200 ordinary shares, 4.6%, via Rivendell Investments 2017-9 LLC4.6% · as of Dec 2025
source ↗Fractyl Health, Inc. — ~6.08M common-equivalent shares via Mithril entities (10% owner at IPO, Feb 2024)GUTS · >10% · as of Feb 2024 · $0.47 ▼ 3.23%
source ↗More
- Ticker
- GUTS
- Stake
- >10% at IPO
- Stake as of
- 2024-02-01
PropertyGuru Group — fully exited (0 shares) via BTN Investments 2 LLC0% · as of Dec 2024
source ↗Investment vehicles
Rivendell 7 LLC / Rivendell 25 LLC / PLTR Holdings LLC / STS Holdings II LLCholding co
source ↗More
- Type
- holding co
- Notes
- Thiel-controlled LLCs holding Palantir stock (Thiel sole beneficial owner per Form 4 footnotes)
Rivendell Investments 2017-9 LLCholding co
source ↗More
- Type
- holding co
- Notes
- holds Chemomab position
BTN Investments 2 LLCholding co
source ↗More
- Type
- holding co
- Notes
- held PropertyGuru stake (exited by 2024-12-31)
Founders Fund IX, LPfund · CIK 0001971631
source ↗More
- Type
- fund
- Notes
- Founders Fund flagship fund entity on EDGAR (Form D filer); 13F status not checked
Real estate
Buenos Aires, Argentina (listed residence)residence · as of 2026-09
source ↗Giving
Thiel Foundation (Thiel Fellowship: $100,000 over two years to skip college)
source ↗Research gaps: Web search budget exhausted; Reuters/Bloomberg/CNBC blocked. Not verified: Valar Ventures, Thiel Capital, Anduril/other Founders Fund 2025-26 deals, Miami Beach and other property purchases, New Zealand holdings, Thiel Foundation EIN (ProPublica rate-limited), litigation. Exact 2026 Palantir stake % from proxy table not extracted.
Prices via Finnhub · as of Sep 24, 2026 4:00 PM ET. For information only.